Commercial, GHG Emissions, Wind - August 17, 2022
Elanco Animal Health Updates Emission Progress
Elanco Animal Health Incorporated reduced the company’s overall impact on the environment by lowering Scope 1 and Scope 2 emissions by approximately 8% compared to 2020 and approximately 40% compared to its 2015 baseline.
The company transitioned its largest manufacturing site in Kiel, Germany to 100% wind energy over the course of 2021, advancing on its goal of sourcing 100% renewable energy by 2030.
Details were provided in its 2021 Environmental, Social and Governance (ESG) Report “Changing The World One Animal at a Time.”
“We are driven by our purpose and integrate opportunities to improve the health of animals, people, the planet and our enterprise into our core business operations,” said Jeff Simmons, CEO at Elanco in a statement. “We are working hard around the globe to increase representation of diverse talent and reduce our own environmental footprint while supporting our customers, advancing their sustainability efforts through environmentally beneficial products, animal welfare consultation and our antimicrobial stewardship guidance.”
The reporting is aligned with the Sustainability Accounting Standards Board (SASB) guideline for the Biotechnology & Pharmaceuticals industry, as well as the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations.